资讯

pharmaphorum7 分钟
AZ claims EU okay for Imfinzi in bladder cancer
The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...
pharmaphorum14 分钟
AZ's Imfinzi set for EU return in bladder cancer
The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...